Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Irvine › NPI 1508487430
Lab

Morningstar Laboratories LLC

Morningstar Laboratories LLC was paid $198K by Medicaid between Nov 2020 and Jan 2023, across 24 billing codes. Its largest line is 84238, — 37% of everything it billed.

33Billing provider infoMORNINGSTAR LABORATORIES LLC
IRVINE, CA 92617
33aNPI1508487430assigned 05/01/2020
28Total paid$198K
24GClaims33,292
24DCodes billed24
24AFirst – last monthNov 2020 – Jan 2023
Compared with peers

Next to other Clinical Medical Laboratory providers in California

Rank by total paid#284 of 561
Median peer was paid$222K
This provider vs. median0.9×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$10K$20K$30K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2020412$11K
202114,177$98K
202218,453$87K
2023250$2K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
84238 37% 4,853 3,717 $74K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 14% 577 246 $27K
83520 13% 4,755 3,639 $26K
82397 8.1% 4,224 3,208 $16K
83036 Hemoglobin; glycosylated (A1C) 4.6% 4,481 3,431 $9K
81229 4.2% 85 45 $8K
83701 2.5% 1,503 1,009 $5K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 2.5% 414 175 $5K
83718 2.2% 4,039 3,235 $4K
82172 2.0% 491 287 $4K
86141 1.6% 1,711 1,162 $3K
86769 1.5% 172 140 $3K
12 more codes
83695 1.4% 1,719 $3K
86328 <1% 48 $2K
81479 Unlisted molecular pathology procedure <1% 300 $2K
81406 <1% 595 $1K
80061 Lipid panel <1% 1,266 $1K
81404 <1% 383 $1K
81405 <1% 382 $898.04
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 30 $874.42
81403 <1% 569 $633.62
81402 <1% 149 $204.44
36415 Collection of venous blood by venipuncture <1% 282 $139.82
83722 <1% 264 $95.92

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHARRINGTON, DOUGLAS (LAB DIRECTOR)
Parent organizationSMART HEALTH DIAGNOSTICS COMPANY
Same official

Other billing entities under HARRINGTON, DOUGLAS

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.